Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |